MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about board meeting

15 Jan 2025 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 to consider and approve Un Audited financial results for quarter and nine months ended 31st December 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.05
Dr. Reddys Labs. 1145.25
Cipla 1359.25
Lupin 2050.95
Zydus Lifesciences 1108.25
View more..